Abstract
The aim of this study was to investigate the effect of preoperative high-dose radiotherapy (25 Gy in 5 fractions over 5 days) on the type-IV collagenase protein profile, in patients with resectable rectal cancer, by gelatin zymography. Biopsy samples of tumour and distant normal mucosa from 12 patients with resectable rectal cancer were obtained pre- and post-radiotherapy. Expression of type-IV collagenases (both pro- and active forms) was studied using gelatin zymography. Enzyme levels were normalized for total protein content of each sample. Rectal cancer specimens expressed both pro (72 kDa) and active (62 kDa) forms of MMP-2 but only the pro form of MMP-9 (92 kDa). Normal mucosa showed expression of the pro forms of MMP-2 and MMP-9 while no active form of either enzyme was detected in any of the samples. A significant three- to fourfold increase (P< 0.01) of active matrix metalloproteinases (MMP)-2 (62 kDa) was seen in malignant rectal mucosa after radiotherapy. The effect of radiotherapy also led to a twofold increase (P = 0.047) of pro MMP-2 (72 kDa) and a two- to threefold increase (P = 0.03) of the precursor form of MMP-9 (92 kDa). In contrast, in normal mucosa expression of the precursor form of MMP-9 (92 kDa) did not change after radiation, and no significant effect on the levels of pro MMP-2 (72 kDa) was observed. Preoperative high-dose radiotherapy leads to an increase in activity of type-IV collagenases in patients with resectable rectal cancer. Type-IV collagenase inhibition may be a useful therapeutic adjunct to radiotherapy in rectal cancer. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abulafi AM and Williams SN (1994) Local recurrence of rectal cancer: the problem, mechanism, management and adjuvant therapy. Br J Surg 81: 7–19
Albini A, Fontanini G, Masiello L, Tacchetti C, Bigini D, Luzzi P, Noonan DM and Stetler-Stevenson WG (1994) Angiogenic potential in vivo by Kaposi’s sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 8: 1237–1244
Azzam H, Arand G, Lippman M and Thompson E (1993) Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85: 1758–1764
Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, Dixon MF and Quirke P (1994) Role of circumferential margin in the local recurrence of rectal cancer. Lancet 344: 707–711
Boag AH and Young ID (1994) Increased expression of 72-kDa type-IV collegenase in prostate adenocarcinoma. Am J Path 144: 585–591
Ballin M, Gomez DE, Sinha CC and Thorgeirsson UP (1988) Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem Biophys Res Commun 154: 832–838
Brown PD, Bloxidge RE, Anderson E and Howell A (1993) Expression of activated gelatinase in human invasive breast cancer. Clin Exp Metastasis 11: 183–189
Chambers AF and Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260–1270
Cedermark B, Johansson H, Rutqvist LE and Wilking N Stockholm Colorectal Cancer Group (1995) The Stockholm 1 trial of pre-operative short-term radiotherapy in operable rectal carcinoma. A prospective randomised trial. Cancer 75: 2269–2275
Chandler S, Coates R, Gearing A, Lury J, Wells G and Bone E (1995) Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 201: 223–226
Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A and Balkwill F (1993 a) Levels of matrix metalloproteinases in bladder cancer correlate with tumour grade and invasion. Cancer Res 53: 5365–5369
Davies B, Miles D, Happerfield L, Naylor M, Bobrow L, Rubens R and Balkwill F (1993 b) Activity of type-IV collagenase in benign and malignant breast disease. Br J Cancer 67: 1126–1131
Duffy MJ and McCarthy K (1998) Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (Review). Int J Oncol 12: 1343–1348
Heussen C Dowdle (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerised substrates. Anal Biochem 102: 196–202
Johnson MD, Kim HC, Chesler L, Tsao-Wu G, Bouck N and Polverini PJ (1994) Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Phys 160: 194–202
Jaziorka M, Haboubi NY, Schofield PF, Ogata Y, Nagase H and Woolley DE (1994) Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int J Colorectal Dis 9: 141–148
Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T and Seiki M (1996) Processing of a precursor of 72-kDa type IV collegenase/gelatinase A by a recombinant membrane type 1 matrix metalloproteinase. Cancer Res 56: 2535
Kleiner D and Stetler-Stevenson W (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325–329
Liabakk N, Talbot I, Smith RA, Wilkinson K and Balkwill F (1996) Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collegenases in colorectal cancer. Cancer Res 56: 190–196
Moll UM, Youngleib GL, Rosinski KB and Quigley JP (1990) Tumour promoter-stimulated Mr92 000 gelatinase secreted by normal and malignant human cells: Isolation and characterisation of the enzyme from HT1080 tumour cells. Cancer Res 50: 6162–6170
Moriya Y, Hojo K, Sawada T and Koyama Y (1989) Significance of lateral node dissection for advanced rectal carcinoma at or below the peitoneal reflection. Dis Colon Rectum 32: 307–315
Marsh PJ, James RD and Schofield PF (1994) Adjuvant pre-operative radiotherapy for locally advanced rectal carcinoma. Dis Colon Rectum 37: 1205–1214
Murphy G and Docherty AJP (1992) The matrix metalloproteinases and their inhibitors. Am J Resp Cell Mol Biol 7: 120–125
Muller D, Wolf C, Abecassis J, Millon R, Engelmann A, Bronner G, Rouyer N, Rio MC, Eber M, Methlin G, Chambon P and Basset P (1993) Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinoma. Cancer Res 53: 165–169
Meyers MH and Ries LA (1989) Cancer patient survival rates: SEER program results for 10 years of follow-up. CA Cancer J Clin 39: 21–32
Nakajima M, Morikawa K, Fabra A Bucana CD and Fidler IJ (1990) Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890–1898
Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, Longcroft JM, Rogers L and Stamp GWH (1992) Stromal expression of 72 kDa type-IV collegenase (MMP-2) and TIMP-2 mRNA in colorectal neoplasia. Am J Pathol 141: 389–396
Pyke C, Ralfkiaer E, Tryggvason K and Dano K (1993) Messenger RNA for two type IV collegenases is located in stromal cells in human colon cancer. Am J Pathol 142: 359–365
Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA and Steele RJC (1998) Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer 78: 1495–1502
Quirke P, Durdey P, Dixon MF and Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet ii: 996–999
Seir CFM, Kubben FJGM, Ganesh S, Heerding MM, Griffioen G, Hanemaaijer R, vanKrieken JHJM, Lamers CBHW and Verspaget HW (1996) Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to overall survival of patients with gastric carcinoma. Br J Cancer 74: 413–417
Sawaya R, Tofilon PJ, Mohanam S, Ali-Osman F and Liotta LA (1994) Induction of tissue-type plasminogen activator and 72-kDa type-1V collegenase by ionizing radiation in rat astrocyte. Int J Cancer 56: 214–218
Sheela S and Kennedy RA (1986) Radiation-induced anchorage-independent growth and collegenase production in diploid human fibroblasts. Carcinogenesis 7: 201–205
Strongin AY, Collier I, Bannikov G, Marmer BL, Grants GA and Goldberg GI (1995) Mechanism of cell surface activation of 72-kDa type IV collegenase. J Biol Chem 270: 5331–5338
Swedish Rectal Cancer Trial (1997) Improved survival with pre-operative radiotherapy in resectable rectal cancer. N Engl J Med 336: 980–987
Stetler-Stevenson WG, Liotta LA and Kliener DE (1993) Extracellular matrix 6: role of matrix metalloproteinases in tumour invasion and metastasis. FASEB J 7: 1434–1441
Turpeenniemi-Hujanen T, Thorgeirsson UP, Hart IR, Grant SS and Liotta LA (1985) Expression of collegenase IV (basement membrane collegenase) activity in murine tumour cell hybrids that differ in metastatic potential. J Natl Cancer Inst 75: 99–103
Tomita T and Iwata K (1996) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas–adenocarcinomas. Dis Colon Rectum 39: 1255–1264
Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J and Ezekowitz RA (1994) Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93: 2357–2364
Urbanski SJ, Edwards DR, Hershfield N, Huchcroft SA, Shaffer E, Sutherland L and Kossakowska AE (1993) Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diag Mol Pathol 2: 81–89
Vu TH, Shipley JM, Bergers JE, Helms JA, Hanahan D, Shapiro SD, Senior RM and Werb Z (1998) MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411–422
Yamagata S, Ito Y, Tanaka R and Shimizu S (1988) Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. Biochem Biophys Res Commun 151: 158–162
Yamagata S, Yoshii Y, Suh JG, Tanaka R and Shimizu S (1991) Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer Lett 59: 51–55
Zucker S, Lysik RM, Zarrabi MH and Moll U (1993) Mr92 000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 53: 140–146
Zeng ZS, Huang Y, Cohen AM and Guillem G (1996) Prediction of colorectal cancer relapse and survival via tissue levels of matrix metalloproteinase-9. J Clin Oncol 14: 3133–3140
Zeng ZS and Guillem JG (1995) Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase I mRNA expression in human colorectal cancer and liver metastasis. Br J Cancer 72: 575–582
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kumar, A., Collins, H., Scholefield, J. et al. Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer. Br J Cancer 82, 960–965 (2000). https://doi.org/10.1054/bjoc.1999.1025
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1025
Keywords
This article is cited by
-
Cytokine and Growth Factor Response in a Rat Model of Radiation Induced Injury to the Submental Muscles
Dysphagia (2021)
-
Effects of radiation on the metastatic process
Molecular Medicine (2018)
-
Biological effects of radiation on cancer cells
Military Medical Research (2018)
-
Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients
Radiation Oncology (2011)
-
Microvessel density as new prognostic marker after radiotherapy in rectal cancer
BMC Cancer (2009)